Globe/CP say Aphria-Tilray combo gets proxy adviser OK

 Globe/CP say Aphria-Tilray combo gets proxy adviser OK

2021-04-06 08:30 ET - In the News

The Globe and Mail reports in its Tuesday edition that ISS and Glass Lewis are recommending Aphria shareholders vote in favour of the Tilray merger. A Canadian Press dispatch to The Globe says that the proxy advisers said Monday that they support the deal announced in December. The deal will see Leamington, Ont.'s, Aphria receive 0.8381 share of Nanaimo, B.C.'s, Tilray for each Aphria common share. The deal appears "sound" because it will deliver $100-million in pretax cost synergies, ISS said. It believes the merger will create the world's largest cannabis business based on pro forma revenues and still leave the combined company with room to grow in Canada, the United States and Europe. "The operations of the combined company in Europe should provide a unique combination of in-country cultivation and distribution licences as well as the capability to export medical cannabis products within the EU on a tariff-free basis," ISS said. Meanwhile, Glass Lewis conducted an independent review of the transaction and believes the deal was structured fairly and reasonably and is favourable to Aphria shareholders. "We are of the view that the transaction represents a favourable risk/reward for Aphria shareholders," it said.

© 2021 Canjex Publishing Ltd. All rights reserved.

Aphria to release Q3 2021 results April 12

 Aphria to release Q3 2021 results April 12

2021-03-31 09:48 ET - News Release

An anonymous director reports

APHRIA INC. TO ANNOUNCE THIRD QUARTER FISCAL 2021 FINANCIAL RESULTS ON APRIL 12, 2021

Aphria Inc. will release its financial results for the third quarter ended Feb. 28, 2021, on April 12, 2021, before market open.

Aphria executives will host a conference call to discuss these results at 9 a.m. ET. To listen to the live call, dial 888-231-8191 from Canada and the United States or 647-427-7450 from international locations and use passcode 6497567. A telephone replay will be available approximately two hours after the call concludes through May 12, 2021. To access the recording, dial 855-859-2056 and use passcode 6497567.

There will also be a simultaneous live webcast available on the investors section of Aphria's website. The webcast will be archived for 30 days.

About Aphria Inc.

Aphria is a leading global cannabis lifestyle consumer packaged goods company with operations in Canada, the United States, Europe and Latin America. Aphria is changing people's lives for the better -- one person at a time -- by inspiring and empowering the worldwide community to live its very best life by providing it with products that meet the needs of mind, body and soul, and invoke a sense of well-being. Aphria's mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health/well-being through high-quality, differentiated brands and innovative products. Headquartered in Leamington, Ont., Aphria cultivates, processes, markets and sells medical and adult-use cannabis, cannabis-derived extracts and derivative cannabis products in Canada under the provisions of the Cannabis Act and globally pursuant to applicable international regulations. Aphria also manufactures, markets and sells alcoholic beverages in the United States.

© 2021 Canjex Publishing Ltd. All rights reserved.